Chulalongkorn Medical Journal

Publication Ethics Statement

All of the manuscripts should be prepared based on strict observation of research and publication ethics guidelines recommended by the Council of Science Editors (http://www.councilscienceeditors.org/), the International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/), and the World Association of Medical Editors (WAME, http://www.wame.org/). All studies involving human subjects or human data must be reviewed and approved by a responsible Institutional Review Board (IRB).

Please refer to the principles embodied in the Declaration of Helsinki (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/) for all investigations involving human materials. Animal experiments also should be reviewed by an appropriate committee (IACUC) for the care and use of animals. Also studies with pathogens requiring a high degree of biosafety should pass review of a relevant committee (IBC). The approval should be described in the Methods section. For studies of humans including case reports, state whether informed consents were obtained from the study participants. The editor of Chulalongkorn Medical Journal may request submission of copies of informed consents from human subjects in clinical studies or IRB approval documents.

The Chulalongkorn Medical Journal follows the guidelines by the Committee on Publication Ethics (COPE, http://publicationethics.org/) that set standards and provide guidelines for best practices in order to meet these requirements. The journal adheres to ensure the standards of expected ethical behavior for all parties related to the act of authors, peer reviewers, and editors.